Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guillain-Barré syndrome involving reproductive system revealed on <sup>18</sup>F-FDG PET/CT: a case report.

Frontiers in immunology·2026
Same author

Research Progress of Composite Films in Postharvest Preservation of Fruits and Vegetables.

Molecules (Basel, Switzerland)·2026
Same author

Gut and skin microbiota of <i>Bufo gargarizans</i> tadpoles respond differently to temperature.

Frontiers in microbiology·2026
Same author

The Association of Remnant Cholesterol with Obstructive Sleep Apnea and Coronary Heart Disease: A Cross-Sectional Study.

Vascular health and risk management·2026
Same author

Insulin like growth factor - insulin like growth factor binding protein family in osteoporosis: mechanistic and clinical insights.

Annals of medicine·2026
Same author

Adrenal Remodeling and Dysfunction Parallel Age-Dependent Hypertension in Spontaneously Hypertensive Rats.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Jun 13, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

Uncoupling protein 2 ablation exacerbates high-salt intake-induced vascular dysfunction.

Shuangtao Ma1, Liqun Ma, Dachun Yang

  • 1Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Third Military Medical University, Chongqing Institute of Hypertension, China.

American Journal of Hypertension
|April 17, 2010
PubMed
Summary

Uncoupling protein 2 (UCP2) protects against high salt diets by reducing oxidative stress and preserving nitric oxide (NO) bioavailability, preventing salt-sensitive hypertension.

More Related Videos

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Related Experiment Videos

Last Updated: Jun 13, 2026

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Renal Physiology

Background:

  • High salt intake is linked to vascular dysfunction, mediated by reactive oxygen species (ROS) and reduced nitric oxide (NO) bioavailability.
  • Uncoupling protein 2 (UCP2) is known to protect against vascular damage by decreasing ROS production.
  • The specific role of UCP2 in vascular function during high salt conditions remains unclear.

Purpose of the Study:

  • To investigate the role of UCP2 in the development of salt-sensitive hypertension and vascular dysfunction in mice subjected to a high-salt diet.

Main Methods:

  • UCP2-deficient (UCP2(-/-)) and wild-type (WT) mice were fed either a normal-salt (NS) or high-salt (HS) diet for 24 weeks.
  • Measurements included blood pressure (BP), mesenteric arterial reactivity, superoxide production, and NO bioavailability.

Main Results:

  • UCP2(-/-) mice on a HS diet exhibited significantly higher BP compared to those on a NS diet.
  • High salt diet impaired vascular reactivity and increased superoxide production while decreasing NO bioavailability, with these effects being more pronounced in UCP2(-/-) mice.
  • WT mice on a HS diet showed impaired vascular function, but this was exacerbated in UCP2(-/-) mice.

Conclusions:

  • UCP2 plays a critical role in preventing salt-sensitive hypertension.
  • UCP2 likely exerts its protective effects by suppressing vascular superoxide production and maintaining nitric oxide bioavailability.
  • Targeting UCP2 may offer a therapeutic strategy for managing salt-induced vascular dysfunction.